- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cancer patients can choose ultrasound while pregnant
Ultrasound provides a safe and accurate method of detecting breast cancer and assessing response to chemotherapy in pregnant women, according to a study in the April issue of Radiology.
Ultrasound provides a safe and accurate method of detecting breast cancer and assessing response to chemotherapy in pregnant women, according to a study in the April issue of Radiology.
Researchers enrolled 23 pregnant women diagnosed with 24 breast cancers who underwent mammography, ultrasound, or a combination of both modalities. They detected 90% of tumors in patients undergoing mammography but found all tumors in every woman who underwent an ultrasound exam. Ultrasound also found cancer metastases in 15 of 18 women undergoing a lymph node assessment.
The study includes the largest group of women to date diagnosed and treated for breast cancer during pregnancy. Data showed that, in addition to diagnosis, ultrasound can help stage cancer and evaluate treatment response, researchers said.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
